H.E.B Extra Strength Antacid Tablets Recall
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
FDA announces ongoing Class II recall of H.E.B Extra Strength Calcium Carbonate Antacid Tablets due to small metallic particles.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on July 9, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, drugs.
What Happened
The recall was initiated due to the presence of foreign substance: small metallic particles in chewable tablets.
Which Products Are Affected
H.E.B Extra Strength Calcium Carbonate Antacid Tablets, Calcium Carbonate 750 mg, 96 Chewable Tablets (NDC 37808-136-22). Lot #: 1276118, expires: JAN 2029. Distributed nationwide in the United States. Recalling firm: Guardian Drug Co. Inc.
What You Should Do
Consumers are advised to check products against the listed lot information and consult the FDA for further guidance on the ongoing recall.
Why This Matters
This Class II recall addresses a foreign substance hazard in an over-the-counter antacid product distributed across the U.S.
Source
FDA recall number D-0573-2026. https://www.fda.gov
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (772 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to July 9, 2026.
Frequently Asked Questions
Common questions about this FDA recall.